These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9871532)

  • 1. Solid phase synthesis of benzylamine-derived sulfonamide library.
    Kim SW; Hong CY; Lee K; Lee EJ; Koh JS
    Bioorg Med Chem Lett; 1998 Apr; 8(7):735-8. PubMed ID: 9871532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deconstruction of sulfonamide inhibitors of the urotensin receptor (UT) and design and synthesis of benzylamine and benzylsulfone antagonists.
    Taylor SJ; Soleymanzadeh F; Muegge I; Akiba I; Taki N; Ueda S; Mainolfi E; Eldrup AB
    Bioorg Med Chem Lett; 2013 Apr; 23(7):2177-80. PubMed ID: 23453841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Solid phase synthesis of benzamidine-derived sulfonamide libraries.
    Kim SW; Hong CY; Koh JS; Lee EJ; Lee K
    Mol Divers; 1997-1998; 3(2):133-6. PubMed ID: 9593184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives.
    Çetinkaya Y; Göçer H; Göksu S; Gülçin İ
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):168-74. PubMed ID: 23391138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological activity of novel purine and bicyclic pyrimidine factor Xa inhibitors.
    Buckman BO; Mohan R; Koovakkat S; Liang A; Trinh L; Morrissey MM
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2235-40. PubMed ID: 9873520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing rapid onset selective serotonin re-uptake inhibitors. Part 3: Site-directed metabolism as a strategy to avoid active circulating metabolites: structure-activity relationships of (thioalkyl)phenoxy benzylamines.
    Middleton DS; Andrews M; Glossop P; Gymer G; Hepworth D; Jessiman A; Johnson PS; MacKenny M; Stobie A; Tang K; Morgan P; Jones B
    Bioorg Med Chem Lett; 2008 Oct; 18(19):5303-6. PubMed ID: 18782666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of novel guanidine/benzamidine mimics: potent and orally bioavailable factor Xa inhibitors as novel anticoagulants.
    Lam PY; Clark CG; Li R; Pinto DJ; Orwat MJ; Galemmo RA; Fevig JM; Teleha CA; Alexander RS; Smallwood AM; Rossi KA; Wright MR; Bai SA; He K; Luettgen JM; Wong PC; Knabb RM; Wexler RR
    J Med Chem; 2003 Oct; 46(21):4405-18. PubMed ID: 14521405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel thrombin inhibitors with azaphenylalanine scaffold.
    Zega A; Trampus-Bakija A; Fortuna M; Stegnar M; Tschopp TB; Steiner B; Urleb U
    Pharmazie; 2001 Sep; 56(9):683-5. PubMed ID: 11593985
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sulfonamide derivatives of benzylamine block cholesterol biosynthesis in HepG2 cells: a new type of potent squalene epoxidase inhibitors.
    Gotteland JP; Loubat C; Planty B; Junquéro D; Delhon A; Halazy S
    Bioorg Med Chem Lett; 1998 Jun; 8(11):1337-42. PubMed ID: 9871762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and Evaluation of Spumigin Analogues Library with Thrombin Inhibitory Activity.
    Žula A; Będziak I; Kikelj D; Ilaš J
    Mar Drugs; 2018 Oct; 16(11):. PubMed ID: 30373260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-374,087, an efficacious, orally bioavailable, pyridinone acetamide thrombin inhibitor.
    Sanderson PE; Cutrona KJ; Dorsey BD; Dyer DL; McDonough CM; Naylor-Olsen AM; Chen IW; Chen Z; Cook JJ; Gardell SJ; Krueger JA; Lewis SD; Lin JH; Lucas BJ; Lyle EA; Lynch JJ; Stranieri MT; Vastag K; Shafer JA; Vacca JP
    Bioorg Med Chem Lett; 1998 Apr; 8(7):817-22. PubMed ID: 9871547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of 4-sulfamoylphenyl-benzylamine derivatives with inhibitory activity against human carbonic anhydrase isoforms I, II, IX and XII.
    Durgun M; Turkmen H; Ceruso M; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):982-8. PubMed ID: 26803577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenolic P2/P3 core motif as thrombin inhibitors--design, synthesis, and X-ray co-crystal structure.
    Hanessian S; Therrien E; van Otterlo WA; Bayrakdarian M; Nilsson I; Fjellström O; Xue Y
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1032-6. PubMed ID: 16290930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of a small library of graftable thrombin inhibitors derived from (L)-arginine.
    Salvagnini C; Gharbi S; Boxus T; Marchand-Brynaert J
    Eur J Med Chem; 2007 Jan; 42(1):37-53. PubMed ID: 17010480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1,2-Disubstituted indole, azaindole and benzimidazole derivatives possessing amine moiety: a novel series of thrombin inhibitors.
    Takeuchi K; Bastian JA; Gifford-Moore DS; Harper RW; Miller SC; Mullaney JT; Sall DJ; Smith GF; Zhang M; Fisher MJ
    Bioorg Med Chem Lett; 2000 Oct; 10(20):2347-51. PubMed ID: 11055353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bicyclic pyridones as potent, efficacious and orally bioavailable thrombin inhibitors.
    Coburn CA; Rush DM; Williams PD; Homnick C; Lyle EA; Lewis SD; Lucas BJ; Di Muzio-Mower JM; Juliano M; Krueger JA; Vastag K; Chen IW; Vacca JP
    Bioorg Med Chem Lett; 2000 May; 10(10):1069-72. PubMed ID: 10843219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2-(2-Chloro-6-fluorophenyl)acetamides as potent thrombin inhibitors.
    Lee L; Kreutter KD; Pan W; Crysler C; Spurlino J; Player MR; Tomczuk B; Lu T
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6266-9. PubMed ID: 17889527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A new non-natural arginine-like amino acid derivative with a sulfamoyl group in the side-chain.
    De Marco R; Di Gioia ML; Leggio A; Liguori A; Perri F; Siciliano C; Viscomi MC
    Amino Acids; 2010 Mar; 38(3):691-700. PubMed ID: 19283444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design of novel groups for use in the P1 position of thrombin inhibitor scaffolds. Part 2: N-acetamidoimidazoles.
    Isaacs RC; Solinsky MG; Cutrona KJ; Newton CL; Naylor-Olsen AM; McMasters DR; Krueger JA; Lewis SD; Lucas BJ; Kuo LC; Yan Y; Lynch JJ; Lyle EA
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2062-6. PubMed ID: 18291642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,2-Dibenzamidobenzene inhibitors of human factor Xa.
    Herron DK; Goodson T; Wiley MR; Weir LC; Kyle JA; Yee YK; Tebbe AL; Tinsley JM; Mendel D; Masters JJ; Franciskovich JB; Sawyer JS; Beight DW; Ratz AM; Milot G; Hall SE; Klimkowski VJ; Wikel JH; Eastwood BJ; Towner RD; Gifford-Moore DS; Craft TJ; Smith GF
    J Med Chem; 2000 Mar; 43(5):859-72. PubMed ID: 10715153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.